COVID-19January 14, 2021
COVID-19 Vaccinations and Psoriatic Disease
COVID-19 vaccines have arrived! COVID-19 Task Force Co-Chairs, dermatologist Dr. Joel Gelfand, Psoriasis and Phototherapy Treatment Center at Penn, and rheumatologist Dr. Christopher Ritchlin, Psoriasis Center, University of Rochester Medical Center return to discuss vaccine safety, effectiveness, and use with psoriatic disease treatments.
This program is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Pfizer and UCB.